author

 
 

Meta

Kanoko Matsuyama
Japan Times
JAPAN / Society
Feb 27, 2013
Seniors forced to go it alone as ranks swell, housing eludes
Itoko Uchida, 82, was counting on the nephew she raised to support her in old age. He refused, forcing her to pay for a sponsor to join the 420,000-long line of Japanese waiting for a nursing home bed.
Japan Times
BUSINESS
Dec 4, 2012
Takeda exec pushing for more women at top
Takeda Pharmaceutical Co. Director Deborah Dunsire, the only female on a board of one of Japan's 10 largest public companies, says the drugmaker is just getting started in promoting more women to senior levels.
Japan Times
BUSINESS
Jul 23, 2011
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says
Takeda Pharmaceutical Co.'s Actos diabetes drug may be kept on the market with new warnings, the European Medicines Agency said after reviewing research showing the drug carried a slightly increased risk of bladder cancer.
JAPAN
Nov 3, 2010
Dieting moms' babies underweight
As soon as Keiko Ozaki found out she was pregnant with her second baby, she went on a diet.
Japan Times
BUSINESS
Jun 2, 2009
Masks with ostrich antibodies aid swine flu fight
Researcher Yasuhiro Tsukamoto's flock of 500 ostriches is being enlisted into the global fight against swine flu by exploiting Japan's practice of wearing masks in public to ward off allergies and colds.
Japan Times
BUSINESS
Apr 7, 2009
Otsuka seen leading race to find TB cure
Hiroshi Ishikawa spent half of his career searching for a tuberculosis cure. Now, after a quarter century, he may have the drug industry's most effective weapon to fight resistant strains of the deadly lung disease.
JAPAN
Feb 20, 2009
Infants at risk as government drags feet on vaccines
Kenta Morioka, 4, died last year from suffocation caused by a bacterial infection. But the vaccine that could have saved his life, in use for 16 years and offered in 120 countries, wasn't available in Japan.
Japan Times
BUSINESS
Feb 29, 2008
Pfizer diverting drug development away from Japan
Pfizer Inc., the world's biggest drugmaker, is diverting drug studies and tests from Japan as part of an industry push to avoid this nation's regulatory delays and higher costs.

Longform

Tokyo Koon stands at the forefront of tackling the so-called 2025 issue, also known as the “Magnetic Tape Alert.”
The race to save 20th-century history